Peptide Therapeutics intermediate
Exenatide - DURATION-1 (NCT00207469)
Duration-1 trial comparing exenatide to glimepiride in type 2 diabetes. This peptide or oligopeptide is studied for its biological activity, structure-activi...
By Encyclopeptide Editorial | 1 min read
exenatide-duration-1-nct00207469 peptide research
Overview
Duration-1 trial comparing exenatide to glimepiride in type 2 diabetes.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Exenatide - DURATION-1 (NCT00207469)” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Exenatide - DURATION-1 (NCT00207469) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept